- Home
- HAS vs ASND Comparison
HAS vs ASND Comparison
Compare HAS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAS | ASND |
|---|---|---|
| Founded | 1923 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | HAS | ASND |
|---|---|---|
| Price | $79.97 | $211.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 15 |
| Target Price | $88.55 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 1.8M | 726.7K |
| Earning Date | 10-23-2025 | 11-12-2025 |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,357,000,000.00 | $758,592,045.00 |
| Revenue This Year | $10.26 | $99.74 |
| Revenue Next Year | $6.23 | $79.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.79 | ★ 97.46 |
| 52 Week Low | $49.00 | $118.03 |
| 52 Week High | $85.15 | $229.94 |
Technical Indicators
Market Signals| Indicator | HAS | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 53.98 |
| Support Level | $79.42 | $192.28 |
| Resistance Level | $85.15 | $229.94 |
| Average True Range (ATR) | 1.97 | 10.29 |
| MACD | -0.21 | 0.72 |
| Stochastic Oscillator | 16.14 | 53.27 |
Price Performance
Historical ComparisonAbout HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.